World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: TCTR
Last refreshed on: 29 April 2024
Main ID:  TCTR20171219001
Date of registration: 19/12/2017
Prospective Registration: No
Primary sponsor: Ministry of Technology and Higher Education of Indonesia
Public title: Evaluating the Effectiveness of Education Session by Pharmacists in Patients with Asthma
Scientific title: A Randomized Controlled Trial Evaluating the Effectiveness of Education Session by Pharmacists in Patients with Asthma in Indonesia
Date of first enrolment: 28/08/2017
Target sample size: 100
Recruitment status: Completed
URL:  https://www.thaiclinicaltrials.org/show/TCTR20171219001
Study type:  Interventional
Study design:  Randomized  
Phase:  N/A
Countries of recruitment
Indonesia
Contacts
Name: Elida    Zairina
Address:  Faculty of Pharmacy, Universitas Airlangga, Jl. Darmawangsa Dalam, Surabaya 60286 Jawa Timur Indonesia
Telephone: 625020514
Email: elida-z@ff.unair.ac.id
Affiliation:  Universitas Airlangga
Name: Elida    Zairina
Address:  Faculty of Pharmacy, Universitas Airlangga, Jl. Darmawangsa Dalam, Surabaya 60286 Jawa Timur Indonesia
Telephone: 625020514
Email: elida-z@ff.unair.ac.id
Affiliation:  Universitas Airlangga
Key inclusion & exclusion criteria
Inclusion criteria: Eligibility for this trial included patients with asthma who had used any regular medications for asthma within the previous 12 months, aged 18 years or older and able to communicate in Indonesian.
Exclusion criteria: Those who are not able or contra indicated to perform lung function with spirometer will be excluded.

Age minimum: 18 Years
Age maximum: 80 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Patients with asthma diagnosed
asthma, asthma control, asthma quality of life
asthma, asthma control, asthma quality of life
Intervention(s)
The trial evaluates an intervention involving pharmacists to deliver one-on-one education session about: (1) asthma medication that has been used (2) how to use asthma medication devices correctly (3) asthma symptoms and how to prevent the asthma exacerbations and (4) how to handle asthma triggers and environmental control measures. The intervention group will also be provided with asthma booklet contains about how to use asthma medication correctly and avoiding asthma triggers
A written asthma action plan consistent with Global Initiative for Asthma (GINA) guideline has been translated into Indonesian language and designed for each participant based on information obtained at baseline. The asthma action plan contains instructions on which medications to take when feeling well, how to recognize worsening asthma, what to do when symptoms are getting worse and what to do in the event of an acute attack, including a first aid plan,Participants allocated to the control group received the usual medical care provided by the Department of Pulmonology and/or their healthcare professionals. This included their regular monthly visits depending on their severity or complications. If during follow up, it was apparent that their asthma control had deteriorated since prior assessment (for example; using their reliever two or more times a week, needing to increase their preventer dose), the participant and her health professionals will be notified with participant’s permission.
Experimental Other,No Intervention Other
Education session by pharmacist,Usual Care
Primary Outcome(s)
Changes in asthma control baseline and every 1, 2 and 3 months Asthma Control Questionnaire (ACQ)
Secondary Outcome(s)
Changes in Asthma Quality of Life baseline and every 1, 2 and 3 months Asthma Quality of Life Questionnaire (AQLQ) ,Forced Expiratory Volume in 1 second (FEV1) baseline and every 1, 2 and 3 months Spirometer,asthma-related health visits, days off work/study, and oral corticosteroid use baseline and at 3 months Questionnaire and patient medical records,Adherence score baseline and every 1, 2 and 3 months Adherence to Refills and Medications Scales (ARMS) questionnaire
Secondary ID(s)
Nil Known
Source(s) of Monetary Support
Ministry of Technology and Higher Education of Indonesia
Secondary Sponsor(s)
Ministry of Technology and Higher Education of Indonesia
Ethics review
Status: Submission not required
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed: 31/08/2018
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history